Ocugen (OCGN) Return on Sales (2020 - 2025)
Ocugen (OCGN) has disclosed Return on Sales for 8 consecutive years, with 87.31% as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Return on Sales rose 10559.0% year-over-year to 87.31%, compared with a TTM value of 14.35% through Dec 2025, down 100.0%, and an annual FY2025 reading of 15.22%, down 186.0% over the prior year.
- Return on Sales was 87.31% for Q4 2025 at Ocugen, up from 9.24% in the prior quarter.
- Across five years, Return on Sales topped out at 1450.98% in Q4 2021 and bottomed at 48.54% in Q2 2023.
- Average Return on Sales over 5 years is 200.96%, with a median of 11.11% recorded in 2024.
- The sharpest move saw Return on Sales surged 136837bps in 2021, then plummeted -148323bps in 2022.
- Year by year, Return on Sales stood at 1450.98% in 2021, then tumbled by -102bps to 32.26% in 2022, then surged by 75bps to 8.18% in 2023, then crashed by -123bps to 18.28% in 2024, then soared by 578bps to 87.31% in 2025.
- Business Quant data shows Return on Sales for OCGN at 87.31% in Q4 2025, 9.24% in Q3 2025, and 10.82% in Q2 2025.